Natco Pharma gets warning letter from USFDA for Telangana plant

Natco Pharma, a pharmaceutical company, received a warning letter from the USFDA regarding its manufacturing plant in Telangana. This came after the FDA conducted an inspection of the company's facility in Kothur last October, issuing eight observations under Form 483.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/LWQxeCP
via IFTTT

0 comments:

Post a Comment